Jefferies Says It's Buying Abbott Labs Stock On Emerging Market Growth, Valuation

By: via Benzinga
Abbott Laboratories (NYSE: ABT) shares are down 6 percent in the last six months, slipping below the $50 mark on August ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.